1. Home
  2. ATPC vs NKTX Comparison

ATPC vs NKTX Comparison

Compare ATPC & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATPC
  • NKTX
  • Stock Information
  • Founded
  • ATPC 2016
  • NKTX 2015
  • Country
  • ATPC Malaysia
  • NKTX United States
  • Employees
  • ATPC N/A
  • NKTX N/A
  • Industry
  • ATPC Medical/Nursing Services
  • NKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ATPC Health Care
  • NKTX Health Care
  • Exchange
  • ATPC Nasdaq
  • NKTX Nasdaq
  • Market Cap
  • ATPC 103.5M
  • NKTX 123.5M
  • IPO Year
  • ATPC N/A
  • NKTX 2020
  • Fundamental
  • Price
  • ATPC $1.67
  • NKTX $1.86
  • Analyst Decision
  • ATPC
  • NKTX Strong Buy
  • Analyst Count
  • ATPC 0
  • NKTX 6
  • Target Price
  • ATPC N/A
  • NKTX $14.40
  • AVG Volume (30 Days)
  • ATPC 136.5K
  • NKTX 441.5K
  • Earning Date
  • ATPC 08-13-2025
  • NKTX 05-14-2025
  • Dividend Yield
  • ATPC N/A
  • NKTX N/A
  • EPS Growth
  • ATPC N/A
  • NKTX N/A
  • EPS
  • ATPC N/A
  • NKTX N/A
  • Revenue
  • ATPC $1,293,141.00
  • NKTX N/A
  • Revenue This Year
  • ATPC N/A
  • NKTX N/A
  • Revenue Next Year
  • ATPC N/A
  • NKTX N/A
  • P/E Ratio
  • ATPC N/A
  • NKTX N/A
  • Revenue Growth
  • ATPC N/A
  • NKTX N/A
  • 52 Week Low
  • ATPC $0.90
  • NKTX $1.31
  • 52 Week High
  • ATPC $6.80
  • NKTX $8.23
  • Technical
  • Relative Strength Index (RSI)
  • ATPC 48.50
  • NKTX 50.25
  • Support Level
  • ATPC $1.46
  • NKTX $1.81
  • Resistance Level
  • ATPC $1.71
  • NKTX $2.08
  • Average True Range (ATR)
  • ATPC 0.18
  • NKTX 0.11
  • MACD
  • ATPC -0.02
  • NKTX 0.02
  • Stochastic Oscillator
  • ATPC 32.86
  • NKTX 42.11

About ATPC Agape ATP Corporation

Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body and various wellness programs. Its segments include: Skin care, health and wellness segment includes the provision of health and wellness products and health solution advisory services; and Green energy segment includes providing renewable energy products, technical solutions, installations and maintenance services. It derives maximum revenue from Skin care, health and wellness segment.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: